Related Experiment Video
Updated: Jul 18, 2026

07:29
Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Buprenorphine use: the international experience.
Maria Patrizia Carrieri1, Leslie Amass, Gregory M Lucas
1INSERM U379, Marseilles, France. Pmcarrieri@aol.com
Summary
Buprenorphine and methadone offer effective treatment for heroin and human immunodeficiency virus (HIV) epidemics. Expanded access may reduce overdose deaths and HIV spread among injection drug users.
Area of Science:
- Addiction Medicine
- Infectious Disease Epidemiology
- Public Health Policy
Background:
- The co-occurrence of heroin injection and human immunodeficiency virus (HIV) epidemics necessitates expanded treatment access.
- Buprenorphine and methadone are recognized as essential medicines by the World Health Organization.
Purpose of the Study:
- To review the effectiveness and challenges of buprenorphine and methadone treatment models for opioid use disorder and HIV.
- To examine buprenorphine diversion factors and international treatment approaches.
Main Methods:
- Review of existing literature and treatment models from France, the United States, Australia, Germany, and Italy.
- Analysis of buprenorphine diversion factors, including dosage, social vulnerability, and prescribing practices.
Main Results:
- France's extensive buprenorphine program is linked to a significant reduction in overdose deaths.
- Buprenorphine diversion is associated with insufficient dosing, social challenges, and polypharmacy.
- International treatment models and specific population use are also discussed.
Conclusions:
- Buprenorphine and methadone are crucial tools for managing dual heroin and HIV epidemics.
- Expanding access to these medications can reduce HIV transmission and improve healthcare engagement for injection drug users.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

